Investigation of N-Aryl-3-alkylidenepyrrolinones as Potential Niemann—Pick Type C Disease Therapeutics

A five-step synthesis of an array of N-aryl-3-alkylidenepyrrolinones, which are potential Niemann−Pick type C (NPC) disease therapeutics, is described. The synthetic route allows for the production of analogues, including photoaffinity and biotinylated derivatives. Compound 1a increased esterification by acyl-coenzyme A:cholesteryl acyltransferase in NPC1 mutant cells. It also decreased LDL uptake and increased cholesterol efflux in both NPC1-deficient and normal cells.